Cardoso L R, Oliveira A V, Santos O F, Boim M A, Razvickas C V, Ajzen H, Schor N
Nephrology Division, Escola Paulista de Medicina, São Paulo, Brazil.
Exp Nephrol. 1997 May-Jun;5(3):217-24.
Endogenous glucocorticoid (GC) has been proposed to play a role in the adaptive functions of remnant nephron and participates in the progression of renal disease. The effect of GC blockade by RU-486 (20 mg/kg), an anti-GC agent, on the progression of chronic renal failure (CRF) was evaluated in Munich-Wistar rats. CRF was induced by 5/6 nephrectomy. Global renal function, glomerular hemodynamics, proteinuria and renal histopathology studies were performed after 60 days of CRF induction. RU administration in control or CRF groups did not induce significant changes in total renal function, mean arterial or intraglomerular hydraulic pressures, 24-hour proteinuria or sclerosis index. However, RU induced a significant reduction in single-nephron glomerular filtration rate in the superficial nephrons in both groups' control (decreases 20%) and CRF (decreases 57%), without changing total glomerular filtration rate, when compared with vehicle administration. These reductions were due to a decline in glomerular plasma flow rate (QA) and in glomerular ultrafiltration coefficient (Kf). These data suggest that GC played a role in the adaptive hyperfiltration associated with the compensatory mechanism but did not participate in the genesis of proteinuria or glomerulosclerosis in this experimental model.
内源性糖皮质激素(GC)被认为在残余肾单位的适应性功能中起作用,并参与肾脏疾病的进展。在慕尼黑-威斯塔大鼠中评估了抗GC药物RU-486(20毫克/千克)阻断GC对慢性肾衰竭(CRF)进展的影响。通过5/6肾切除术诱导CRF。在诱导CRF 60天后进行整体肾功能、肾小球血流动力学、蛋白尿和肾脏组织病理学研究。在对照组或CRF组中给予RU,未引起总肾功能、平均动脉压或肾小球内液压、24小时蛋白尿或硬化指数的显著变化。然而,与给予载体相比,RU使两组(对照组降低20%,CRF组降低57%)浅表肾单位的单肾单位肾小球滤过率显著降低,而总肾小球滤过率未改变。这些降低是由于肾小球血浆流速(QA)和肾小球超滤系数(Kf)下降所致。这些数据表明,在该实验模型中,GC在与代偿机制相关的适应性超滤中起作用,但不参与蛋白尿或肾小球硬化的发生。